Skip to main content
. 2017 Jan 6;12(1):e0169128. doi: 10.1371/journal.pone.0169128

Fig 1. ACY-957 and ACY-1035 selectively inhibits HDAC1 and 2.

Fig 1

(A) In vitro biochemical assay for HDAC1, HDAC2 or HDAC3 inhibition by ACY-957 (left panel) and ACY-1035 (right panel). Mean ± SD, n = 3. (B) MV-4-11, Kasumi-1 or HL-60 cells were treated with the indicated doses of compounds for 24 hours and immunoblotting performed for acetylated H2BK5, acetylated H3K56 and total H4. A dose-dependent induction of histone acetylation by ACY-957 or ACY-1035 was observed.